Cargando…

Revisiting stroma in pancreatic cancer

Detalles Bibliográficos
Autores principales:	Khan, Sheema, Jaggi, Meena, Chauhan, Subhash C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2015
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4671936/ https://www.ncbi.nlm.nih.gov/pubmed/26682261

Ejemplares similares

MUC13 contributes to rewiring of glucose metabolism in pancreatic cancer
por: Kumari, Sonam, et al.
Publicado: (2018)

Novel Mechanistic Insight into the Anticancer Activity of Cucurbitacin D against Pancreatic Cancer (Cuc D Attenuates Pancreatic Cancer)
por: Sikander, Mohammed, et al.
Publicado: (2019)

Integrative big transcriptomics data analysis implicates crucial role of MUC13 in pancreatic cancer
por: Dhasmana, Anupam, et al.
Publicado: (2023)

Protein kinase D1 regulates metabolic switch in pancreatic cancer via modulation of mTORC1
por: Kumari, Sonam, et al.
Publicado: (2019)

Current status and implications of microRNAs in ovarian cancer diagnosis and therapy
por: Zaman, Mohd Saif, et al.
Publicado: (2012)

Steviol Represses Glucose Metabolism and Translation Initiation in Pancreatic Cancer Cells
por: Kumari, Sonam, et al.
Publicado: (2021)

Protein Kinase D1 attenuates tumorigenesis in colon cancer by modulating β-catenin/T cell factor activity
por: Sundram, Vasudha, et al.
Publicado: (2014)

Antibody-Drug Conjugates for Cancer Therapy: Chemistry to Clinical Implications
por: Dan, Nirnoy, et al.
Publicado: (2018)

Development of polyvinylpyrrolidone/paclitaxel self-assemblies for breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2018)

MicroRNA-145 targets MUC13 and suppresses growth and invasion of pancreatic cancer
por: Khan, Sheema, et al.
Publicado: (2014)

Gemcitabine Combination Nano Therapies for Pancreatic Cancer
por: Samanta, Kamalika, et al.
Publicado: (2019)

Pluronic Polymer-Based Ormeloxifene Nanoformulations Induce Superior Anticancer Effects in Pancreatic Cancer Cells
por: Chauhan, Neeraj, et al.
Publicado: (2020)

Mucins in ovarian cancer diagnosis and therapy
por: Chauhan, Subhash C, et al.
Publicado: (2009)

Curcumin Nanoformulation for Cervical Cancer Treatment
por: Zaman, Mohd S., et al.
Publicado: (2016)

Cucurbitacin D Reprograms Glucose Metabolic Network in Prostate Cancer
por: Sikander, Mohammed, et al.
Publicado: (2019)

Scope of nanotechnology in ovarian cancer therapeutics
por: Yallapu, Murali M, et al.
Publicado: (2010)

Tannic Acid Induces Endoplasmic Reticulum Stress-Mediated Apoptosis in Prostate Cancer
por: Nagesh, Prashanth K.B., et al.
Publicado: (2018)

MUC13 drives cancer aggressiveness and metastasis through the YAP1-dependent pathway
por: Doxtater, Kyle, et al.
Publicado: (2023)

Clinical Implications of Exosomes: Targeted Drug Delivery for Cancer Treatment
por: Massey, Andrew E., et al.
Publicado: (2021)

Curcumin Attenuates β-catenin Signaling in Prostate Cancer Cells through Activation of Protein Kinase D1
por: Sundram, Vasudha, et al.
Publicado: (2012)

T cells in pancreatic cancer stroma
por: Goulart, Michelle R, et al.
Publicado: (2021)

Pancreatic cancer, stroma, and exosomes
por: Closa, Daniel
Publicado: (2022)

miR-205: A Potential Biomedicine for Cancer Therapy
por: Chauhan, Neeraj, et al.
Publicado: (2020)

miRNA-205 Nanoformulation Sensitizes Prostate Cancer Cells to Chemotherapy
por: Nagesh, Prashanth K. B., et al.
Publicado: (2018)

Synthesis and Antitumor Activity of Brominated-Ormeloxifene (Br-ORM) against Cervical Cancer
por: Sikander, Mohammed, et al.
Publicado: (2023)

Biomolecule-functionalized nanoformulations for prostate cancer theranostics
por: Pranav, et al.
Publicado: (2022)

Intestinal helminths – An old foe revisited
por: Parija, Subhash Chandra
Publicado: (2017)

Transient targeting of the pancreatic cancer stroma as a ‘fine-tuned’ anti-tumor and anti-metastatic therapy
por: Vennin, Claire, et al.
Publicado: (2017)

Novel Paclitaxel Nanoformulation Impairs De Novo Lipid Synthesis in Pancreatic Cancer Cells and Enhances Gemcitabine Efficacy
por: Shetty, Advait, et al.
Publicado: (2020)

Reprogramming of pancreatic adenocarcinoma immunosurveillance by a microbial probiotic siderophore
por: Chaib, Mehdi, et al.
Publicado: (2022)

B cells in pancreatic cancer stroma
por: Delvecchio, Francesca Romana, et al.
Publicado: (2022)

Targeting the Stroma in the Management of Pancreatic Cancer
por: Edwards, Penelope, et al.
Publicado: (2021)

MUC13 Interaction with Receptor Tyrosine Kinase HER2 Drives Pancreatic Ductal Adenocarcinoma Progression
por: Khan, Sheema, et al.
Publicado: (2016)

Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma
por: Garcia, Paloma E., et al.
Publicado: (2020)

Soluble stroma‐related biomarkers of pancreatic cancer
por: Resovi, Andrea, et al.
Publicado: (2018)

Natural killer cells in pancreatic cancer stroma
por: Fincham, Rachel Elizabeth Ann, et al.
Publicado: (2021)

Interaction of curcumin nanoformulations with human plasma proteins and erythrocytes
por: Yallapu, Murali Mohan, et al.
Publicado: (2011)

Bioactive nanotherapeutic trends to combat triple negative breast cancer
por: Chowdhury, Pallabita, et al.
Publicado: (2021)

Glutathione-Responsive Tannic Acid-Assisted FRET Nanomedicine for Cancer Therapy
por: Laskar, Partha, et al.
Publicado: (2023)

Targeting Tumor Stroma: Exploiting Apoptotic Priming
por: Mertens, Joachim C., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_3n1c7tp9i0endvoialqmakc8tv